NEW YORK (TheStreet) -- Pfizer's (PFE) shares fell slightly in premarket trading after the pharmaceutical company said Thursday it would explore the sale of its animal health and nutrition businesses.
The New York company, in a press release, said it hoped to maximize shareholder value with a full or partial separation of the two businesses, which included a sale, spinoff or other transaction.
The company said that it had asked JPMorgan (JPM) to evaluate the business alternatives for the two units. Pfizer expected a transaction to occur for each division within the next one to two years.
"Both Animal Health and Nutrition are strong businesses," said Ian Read, Pfizer's CEO. "In exploring these alternatives, we can determine what options will best drive their future growth opportunities and expansion, and enable shareholders to potentially realize higher value for these businesses."Pfizer's animal health unit develops vaccines and medicines for pets and livestock. It was established in 1959 and has annual sales of about $3.6 billion. The nutrition unit, which has sales of about $1.9 billion, has provided medicine for children and infants for about a century, Pfizer said on its Web site. Pfizer shares were down 20 cents to $20.58 in premarket trading Thursday. -- Written by Joe Deaux in New York.
>To submit a news tip, send an email to: firstname.lastname@example.org
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV